SureTrader Advertisement PRTC
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, flaflyersfan, Doubledown22, Stock Barber, baryoboy, KBing617
Search This Board:
Last Post: 5/28/2016 4:01:05 PM - Followers: 470 - Board type: Free - Posts Today: 0


About the Company:

EP Global Communications, Inc. is an Advanced Technology Research and Development company for both Medical Devices and Consumer Electronics Devices specializing in Microelectronic Mechanical Systems (MEMS). For more information about the company, please click on the banner above to be directed to the comapny website.

People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.

One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company has significant know-how and Intellectual Property in the arena of BioMEMS and has invented new device technologies which include, but are not limited to the following:
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
EPGL develops advanced technololgies and in negotiations currently to license them to medical device companies and consumer electronic companies.

Contract with CooperVision:
EPGL and CooperVision, Inc. (CooperVision) have signed an exclusive Development Agreement for Advanced Ophthalmic and Medical Technologies. CooperVision is a market leader in the manufacturing and marketing of contact lenses. The Cooper Companies recently completed the acquisition of Sauflon Pharmaceuticals Limited for approximately $1.2 Billion Dollars.

Material Disclosure to Shareholdrs EPGL MED JOINT PATENT VALIDATION
(Includes EPGL MED, COOPERVISION, David T.Markus, Aurthur Back, Luke A.Kilyk, Michael Hayes)

CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B Ophthalmic Technologies Discoveries Could Revolutionize the Future of Eye Care

CooperVision, Inc. Asks EP Global Communications, Inc. to Grant Option to License Immediately EPGL Considering its Options in Light of the Early Request

Exclusive Development Agreement Signed with CooperVision, Inc., a Division of The Cooper Companies, Inc. (COO, NYSE)

Contract with Intel:
On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an Initial Agreement. Additional Agreements are now pending. EPGL management believes that a relationship with Intel will be advantageous to shareholders as the two companies have synergistic goals in various fields. Details of further Agreements will be available upon mutual decision of the parties to disclose them publicly.

On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an initial Agreement. Additional Agreements are now pending.

Contract with AT&T: 
A new Development Agreement has been executed between AT&T and EPGL on January 4, 2015. As a result of this agreeement Joint Intellectual Properties are now being developed certain data streaming projects in mind. EPGL continues to create new and innovative technologies with large companies
New** EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties (4/28/15)

EPGL and AT&T Developing Joint Intellectual Properties Companies Sign Development Agreement Resulting in New Inventions in IoT Data Streaming Space

EPGL and AT&T Sign Development Agreement

About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so. As of Start of January 2015 Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares.  Reduction of A/S and O/S is currently ongoing and first evidence of EPGL reducing shares will be shown in upcoming Quartley Report  Q3, 2015
** Press Release **  - Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares Beginning January 2015

** OTC Disclosure ** - Supplemental Information- Retirement of Common Shares by Beneficial Shareholders Commences

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) Worlds Largest Accounting Firm
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restruture in 2012***
Total number of shareholders of record 700 approximate 

The Company leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**

Additional Information :
Letter From PricewaterhouseCoopers (Ian Stokoe) Congratulating EPGL on First  Devlopment Agreement (CooperVision)

Follow EPGL on Twiter @epglMED
Follow EPGL on the WEB at



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#103045  Sticky Note $EPGL DD SHEET ** Johnson & Johnson EXCLUSIVE vikingzskillz 04/30/16 11:54:14 AM
#102976  Sticky Note Link to EP Global Communications 4/28/16 Conference call; flaflyersfan 04/29/16 10:15:58 AM
#97811  Sticky Note EP Global Communications, Inc. Reaches Settlement Agreement with vikingzskillz 02/09/16 02:25:24 PM
#95482  Sticky Note Press releases or other company communication should not IH Admin [Brian] 01/12/16 12:14:18 PM
#104825   we cant expect some news this week end franck92 05/28/16 04:01:05 PM
#104824   Which financials are you having trouble with? Scutterflux 05/27/16 07:50:59 PM
#104823   This has nothing to do with what I said. Scutterflux 05/27/16 07:45:58 PM
#104821   Long, so long, zzzzzzzzzzzzzzzzzz. It is the story franck92 05/27/16 05:02:00 PM
#104820   Well maybe not around the Globe but providing DBS 05/27/16 01:52:05 PM
#104819   "When is Memorial Day in 2016?" Donguri 05/27/16 01:42:53 PM
#104818   I was an ICBM launch officer. Thank Koog 05/27/16 11:35:42 AM
#104817   My dad flies jets for the USN and integral 05/27/16 11:06:57 AM
#104815   Anyone that maliciously produces fraudulent financial statements to integral 05/27/16 10:55:20 AM
#104814   Soldiers never consider themselves nor do they boast Shotime66 05/27/16 10:47:54 AM
#104810   Manipulation, someone has to have the power to AHKT456 05/27/16 09:35:08 AM
#104809   @EPGLMed $EPGL - THANK YOU FOR YOUR SERVICE vikingzskillz 05/27/16 09:32:18 AM
#104807   We'll see, we'll see. as the saying goes, allegiant 05/27/16 04:19:20 AM
#104804   Disagree 100% absolutly nothing wrong with last tweet, Scutterflux 05/26/16 11:14:49 PM
#104803   Agreed 100%. Damn shame. thephenomenon 05/26/16 10:09:21 PM
#104802   The idiot that spends his time tweeting like Koog 05/26/16 09:02:38 PM
#104801   EPGL should utilize its resources on someone who integral 05/26/16 08:58:58 PM
#104800   EPGL, keeps tweeting about the "Photo" Hyd 05/26/16 08:48:04 PM
#104798   I was referring to Nowies reply to my post... Shotime66 05/26/16 07:26:21 PM
#104797   Huh H8ster 05/26/16 07:06:54 PM
#104794   Thanks once again for posting facts based on facts. Shotime66 05/26/16 06:43:04 PM
#104793  Restored That is answer is that there are zero/no H8ster 05/26/16 04:56:12 PM
#104786   always same reason GREEEEEEEEED nowy257 05/26/16 01:00:54 PM
#104785   I doubt it is but I agree. Go $EPGL!! 4u2nv2 05/26/16 12:56:31 PM
#104784   I am looking for a old fashioned PR. The dead cat bouncer 05/26/16 12:56:21 PM
#104783   go $EPGL !! This should be within Tos vikingzskillz 05/26/16 12:54:25 PM
#104780   Just wonder if Michael will let us know Shotime66 05/26/16 12:12:47 PM
#104779   Just look at that ACCUMULATION! Shotime66 05/26/16 12:06:21 PM
#104778   No! No! Say it ain't so Joe! Shotime66 05/26/16 12:04:14 PM
#104777   not a chance. Atlanta1 05/26/16 11:59:28 AM
#104776   Looks like EPGL has their ducks in a Shotime66 05/26/16 11:57:44 AM
#104773   right on that stinky bid nowy257 05/26/16 11:29:15 AM
#104771   You know it CV! Shotime66 05/26/16 10:51:26 AM
#104770   Ok thanks. Shotime66 05/26/16 10:50:15 AM
#104769   yes, sad but true. Atlanta1 05/26/16 10:38:31 AM
#104768  Restored the only news u can expect is JNJ CommonVestor 05/26/16 10:36:15 AM
#104767   what is volume on this future $50B company nowy257 05/26/16 10:27:58 AM
#104766   its based on simple logic , just watch nowy257 05/26/16 10:21:47 AM
#104765   Could be Charlie!! Shotime66 05/26/16 10:18:06 AM
#104764   And this information is based on what facts? Shotime66 05/26/16 10:16:57 AM
#104763   no patent approval means EPGL is dead in nowy257 05/26/16 10:13:48 AM
#104762   the only news u can expect is JNJ nowy257 05/26/16 10:12:34 AM
#104761   What day of the week is it???? CancunCharlie 05/26/16 10:04:00 AM
#104760   Will we see NEWS today???? Shotime66 05/26/16 09:47:43 AM
#104757  Restored Reading here on this board one would vikingzskillz 05/26/16 08:25:48 AM
#104756   no, I mean a pre-bias based on the audience. Atlanta1 05/26/16 08:07:56 AM
#104753   That's ok :) so far survey shows what's vikingzskillz 05/26/16 07:48:25 AM
#104752   yep!! I hope something happens sooner or later....LOL gman22 05/26/16 06:53:04 AM
#104751   I think eventually, it will come up though. allegiant 05/26/16 04:56:11 AM
#104750   Can't wait until EPGL's value rises significantly and gman22 05/26/16 12:50:32 AM